Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 1306548

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 1306548

Global Cervical Dysplasia Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

PUBLISHED:
PAGES: 127 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF (10-user License)
USD 5450
PDF (Corporate User License)
USD 8600

Add to Cart

The global demand for Cervical Dysplasia Market is presumed to reach the market size of nearly USD 1167.29 MN by 2030 from USD 620.93 MN in 2022 with a CAGR of 8.21% under the study period 2023 - 2030.

Cervical dysplasia, or cervical intraepithelial neoplasia (CIN), manifests as an abnormal growth of cells on the surface of the cervix. The cervix, which is the lower part of the uterus extending into the vagina, is where this condition is commonly identified during routine cervical cancer screening tests like a Pap smear or human papillomavirus (HPV) test.

MARKET DYNAMICS:

Increasing awareness about cervical cancer and the importance of early detection through screening programs and educational campaigns contributes to market growth. These initiatives have led to higher screening rates and improved patient management. The introduction and uptake of HPV vaccines are other significant drivers, as HPV infection is the primary cause of cervical dysplasia. Vaccination programs targeting the prevention of HPV infection assist in reducing the occurrence of cervical dysplasia. Technological advancements in diagnostic methods, such as liquid-based cytology and molecular testing, have enhanced the accuracy of cervical dysplasia detection. This has improved patient outcomes and treatment decisions. The increasing incidence of HPV-related infections, particularly high-risk HPV types, also drives the market. Government initiatives, guidelines, and policies that promote HPV vaccination and national screening programs play a crucial role. These initiatives provide a framework for preventive measures and early detection strategies, influencing market growth. Ongoing research and development activities focused on innovative diagnostics, therapeutic approaches, and HPV vaccines contribute to advancements in the field and drive the market.

The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cervical dysplasia. The growth and trends of cervical dysplasia industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cervical dysplasia market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Diagnosis Type

  • Diagnostic Tests (HPV Test, Pap Smear Test, Biopsy Test)
  • Diagnostic Devices (Colposcope)

By End-use

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cervical Dysplasia market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cervical dysplasia market include Qiagen N.V., Quest Diagnostics, Abbott Laboratories, Hologic, Inc., Karl Kaps GmbH & Co. KG, DYSIS Medical Ltd., CooperSurgical Inc., Micromedic Technologies Ltd., OncoHealth Corporation, Inc., BD, Roche. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.

Product Code: VMR112111471

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CERVICAL DYSPLASIA - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Diagnosis Type
    • 3.7.2 Market Attractiveness Analysis By End-use
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CERVICAL DYSPLASIA MARKET ANALYSIS BY DIAGNOSIS TYPE

  • 5.1 Overview by Diagnosis Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Diagnosis Type
  • 5.4 Diagnostic Tests (HPV Test, Pap Smear Test, Biopsy Test) Historic and Forecast Sales by Regions
  • 5.5 Diagnostic Devices (Colposcope) Historic and Forecast Sales by Regions

6 . GLOBAL CERVICAL DYSPLASIA MARKET ANALYSIS BY END-USE

  • 6.1 Overview by End-use
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by End-use
  • 6.4 Hospitals Historic and Forecast Sales by Regions
  • 6.5 Diagnostic Centers Historic and Forecast Sales by Regions
  • 6.6 Ambulatory Surgical Centers Historic and Forecast Sales by Regions

7 . GLOBAL CERVICAL DYSPLASIA MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE CERVICAL DYSPLASIA COMPANIES

  • 8.1. Cervical Dysplasia Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF CERVICAL DYSPLASIA INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Qiagen N.V.
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Quest Diagnostics
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Abbott Laboratories
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Hologic Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Karl Kaps GmbH & Co. KG
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. DYSIS Medical Ltd.
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. CooperSurgical Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Micromedic Technologies Ltd.
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. OncoHealth Corporation Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. BD
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Roche
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

Product Code: VMR112111471

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Diagnosis Type (USD MN)
  • Diagnostic Tests (HPV Test, Pap Smear Test, Biopsy Test) Market Sales by Geography (USD MN)
  • Diagnostic Devices (Colposcope) Market Sales by Geography (USD MN)
  • Analysis Market by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Diagnostic Centers Market Sales by Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales by Geography (USD MN)
  • Global Cervical Dysplasia Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cervical Dysplasia
  • Market Research Process
  • Market Research Methodology
  • Global Cervical Dysplasia Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Diagnosis Type
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Diagnosis Type (USD MN)
  • Diagnostic Tests (HPV Test, Pap Smear Test, Biopsy Test) Market Sales by Geography (USD MN)
  • Diagnostic Devices (Colposcope) Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Diagnostic Centers Market Sales by Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the and are not limited to the TOC.

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!